XML 68 R125.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Segment Information (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues | $ 3,671.3 | $ 3,600.1 | $ 3,616.7 | $ 3,489.8 | $ 3,526.3 | $ 3,439.0 | $ 3,356.5 | $ 3,131.1 | $ 14,377.9 | $ 13,452.9 | $ 12,273.9
Geographic information |  |  |  |  |  |  |  |  |  |  |
Long-lived assets | 3,674.3 |  |  |  | 3,601.2 |  |  |  | 3,674.3 | 3,601.2 | 3,182.4
U.S |  |  |  |  |  |  |  |  |  |  |
Geographic information |  |  |  |  |  |  |  |  |  |  |
Long-lived assets | 1,493.2 |  |  |  | 1,152.7 |  |  |  | 1,493.2 | 1,152.7 | 1,226.9
Europe |  |  |  |  |  |  |  |  |  |  |
Geographic information |  |  |  |  |  |  |  |  |  |  |
Long-lived assets | 2,162.9 |  |  |  | 2,442.8 |  |  |  | 2,162.9 | 2,442.8 | 1,948.2
Asia |  |  |  |  |  |  |  |  |  |  |
Geographic information |  |  |  |  |  |  |  |  |  |  |
Long-lived assets | 6.2 |  |  |  | 3.9 |  |  |  | 6.2 | 3.9 | 5.2
Other |  |  |  |  |  |  |  |  |  |  |
Geographic information |  |  |  |  |  |  |  |  |  |  |
Long-lived assets | 12.0 |  |  |  | 1.8 |  |  |  | 12.0 | 1.8 | 2.1
Revenues from anti-cd20 therapeutic programs |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues | 600.8 | 595.8 | 576.4 | 517.4 | 534.9 | 511.7 | 490.4 | 443.2 | 2,290.4 | 1,980.2 | 1,559.2
Revenues from anti-cd20 therapeutic programs | U.S |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 2,211.9 | 1,903.4 | 1,475.6
Revenues from anti-cd20 therapeutic programs | Europe |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 0.2 | 0.2 | 0.6
Revenues from anti-cd20 therapeutic programs | Asia |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 0.0 | 0.0 | 0.0
Revenues from anti-cd20 therapeutic programs | Other |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 78.3 | 76.6 | 83.0
Other revenue |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues | 145.7 | 109.6 | 160.0 | 292.4 | 165.7 | 147.2 | 108.6 | 164.4 | 707.7 | 585.9 | 360.0
Other revenue | U.S |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 585.8 | 457.0 | 249.5
Other revenue | Europe |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 9.7 | 32.7 | 67.8
Other revenue | Asia |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 112.2 | 96.2 | 42.7
Other revenue | Other |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 0.0 | 0.0 | 0.0
Product, net |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues | $ 2,924.8 | $ 2,894.7 | $ 2,880.3 | $ 2,680.0 | $ 2,825.7 | $ 2,780.1 | $ 2,757.5 | $ 2,523.5 | 11,379.8 | 10,886.8 | 10,354.7
Product, net | U.S |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 6,713.8 | 6,800.5 | 7,017.1
Product, net | Europe |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 3,794.5 | 3,370.3 | 2,844.8
Product, net | Asia |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | 320.3 | 281.2 | 160.1
Product, net | Other |  |  |  |  |  |  |  |  |  |  |
Revenue, Major Customer [Line Items] |  |  |  |  |  |  |  |  |  |  |
Product Revenues |  |  |  |  |  |  |  |  | $ 551.2 | $ 434.8 | $ 332.7

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_EntityWideRevenueMajorCustomerLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_NoncurrentAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentsGeographicalAreasAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=biib_SegmentGeographicalGroupsOfCountriesGroupOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=biib_Revenuesfromanticd20therapeuticprogramsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |